Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

Title: Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

Volume: 9 Issue: 2

Author(s): Alberto Lazaro, Gloria Alvarez-Llamas, Julio Gallego-Delgado, Fernando de la Cuesta, Julio Osende, Ma Eugenia G. Barderas and Fernando Vivanco

Affiliation:

Keywords: Atherosclerosis, cardiac hypertrophy, proteomics, pharmacoproteomics

Abstract: Proteomics applications to study the molecular effects of drug administration (pharmacoproteomics) on left ventricular hypertrophy (LVH) and atherosclerosis are here reviewed. In most cases, an absence of complete normalization after treatment is revealed, in contrast to what is reported by classical approaches.

Cite this article as:

Lazaro Alberto, Alvarez-Llamas Gloria, Gallego-Delgado Julio, de la Cuesta Fernando, Osende Julio, Barderas G. Ma Eugenia and Vivanco Fernando, Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis, Cardiovascular & Hematological Disorders-Drug Targets 2009; 9 (2) . https://dx.doi.org/10.2174/187152909788488672